BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:57 PM
Aug 18, 2008
 |  BC Extra  |  Company News

NICE recommends limited use for Adenuric

In a final appraisal, U.K.'s NICE recommended Adenuric febuxostat from Ipsen (Euronext:IPN) to manage chronic hyperuricemia in gout, but only for patients who...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >